Drug firm fined for huge price rise that hit NHS
Advanz pushed up the price of thyroid tablet packs more than 10-fold, says the competition watchdog. …
This specialisation, the Advanz website boasts, “provides essential cost-savings to the NHS and wider European healthcare”. The Competition and Markets Authority’s investigation found another motivation, at least when it came to the supply of one type of thyroid tablets, which contain the chemical liothyronine, to the NHS.